Neopharmed Gentili in the acquisition of Valeas

The firm advised Neopharmed Gentili S.p.A., Italian pharmaceutical company entirely owned by the private equity fund Ardian, for the finance aspects related to the acquisition of the entire share capital of Valeas, a Milan-based pharmaceutical company.

The transaction has been followed by a team composed by partners Lorenzo Vernetti and Gian Luca Coggiola and associate Valentina Calò.